CAS number：1323077-89-9 molecular formula：C20H19N5O3
Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus ( RSV ) infection In Vitro Respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) imposes a substantial medical burden. Enzaplatovir is a small-molecule RSV entry inhibitor. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:RSV
| Chinese alias | 恩扎普拉托韦 | ||
| English alias | Enzaplatovir | Enzaplatovir [INN] | AKOS040748322 | OZ40XB915E | (3R)-4-(3-methyl-1,2-oxazole-4-carbonyl)-3-(6-methylpyridin-3-yl)-1,4,7-triazatricyclo[7.3.0.03,7]dodeca-9,11-dien-8-one | UNII-OZ40XB915E | Q27285922 | ENZAPLATOVIR [WHO-DD] | SCHEMBL233723 | ||
| CAS number | 1323077-89-9 | molecular formula | C20H19N5O3 |
| molecular weight | 377.40 g/mol | Exact mass | ≥99% |
| PSA | 84.500 Ų | logp | 0.700 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
